Quantitative MRI studies of chronic brain white matter hyperintensities in migraine patients

Headache

Volumn 53, Issue 5, 2013, Pages 752-763

  Aradi, Mihály ^a   Schwarcz, Attila ^b,c   Perlaki, Gábor ^a,c   Orsi, Gergely ^a,c   Kovács, Norbert ^d   Trauninger, Anita ^d   Kamson, David Olayinka ^d   Erdélyi Bótor, Szilvia ^d   Nagy, Ferenc ^e   Nagy, Szilvia Anett ^a,b   Dóczi, Tamás ^b,c   Komoly, Sámuel ^d   Pfund, Zoltán ^d  

^a Diagnostic Center of Pecs   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

^e Kaposi Mor County Hospital   (Hungary)

Author keywords

brain white matter hyperintensity; migraine; quantitative 3.0 Tesla magnetic resonance imaging; repeated hemodynamic change

Indexed keywords

CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN WATER; CELL DENSITY; CHRONIC WHITE MATTER HYPERINTENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EXTRACELLULAR SPACE; FEMALE; GLIA CELL; HEMODYNAMICS; HUMAN; IMAGE ANALYSIS; MALE; MICROVASCULAR ISCHEMIA; MIGRAINE; NERVE FIBER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK FACTOR; STATISTICAL ANALYSIS; TISSUE INJURY; WHITE MATTER; WHITE MATTER LESION;

ADULT; AGED; BRAIN; CHRONIC DISEASE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NERVE FIBERS, MYELINATED; YOUNG ADULT;

EID: 84876799756     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12013     Document Type: Article

References (44)

1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia. 2004; 24 (Suppl. 1): 1-160.
2. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine is a risk factor for subclinical brain lesions. JAMA. 2004; 291: 427-434.
3. Kruit MC, Launer LJ, Ferrari MD, van, Buchem MA,. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain. 2005; 128: 2068-2077.
4. Kruit MC, Launer LJ, Ferrari MD, van, Buchem MA,. Brain stem and cerebellar hyperintense lesions in migraine. Stroke. 2006; 37: 1109-1112.
5. Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD,. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulations: The population-based MRI CAMERA study. Cephalalgia. 2010; 30: 129-136.
6. Kurth T, Mohamed S, Maillard P, et al. Headache, migraine, and structural brain lesions and function: Population based Epidemiology of Vascular Ageing-MRI study. BMJ. 2011; 342: c7357.
7. Swartz RH, Kern RZ,. Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis. Arch Neurol. 2004; 61: 1366-1368.
8. Fazekas F, Koch M, Schmidt R, et al. The prevalence of cerebral damage varies with migraine type: A MRI study. Headache. 1992; 32: 287-291.
9. De Benedittis G, Lorenzetti A, Sina C, Bernasconi V,. Magnetic resonance imaging in migraine and tension-type headache. Headache. 1995; 35: 264-268.
10. Schmitz N, Admiraal-Behloul F, Arkink EB, et al. Attack frequency and disease duration as indicators for brain damage in migraine. Headache. 2008; 48: 1044-1055.
11. Trauninger A, Leél-Ossy E, Kamson DO, et al. Risk factors of migraine-related brain white matter hyperintensities: An investigation of 186 patients. J Headache Pain. 2011; 12: 97-103.
12. Bednarczyk EM, Remler B, Weikart C, Nelson AD, Reed RC,. Global cerebral blood flow, blood volume, and oxygen metabolism in patients with migraine headache. Neurology. 1998; 50: 1736-1740.
13. Rocca MA, Colombo B, Inglese M, Codella M, Comi G, Filippi M,. A diffusion tensor magnetic resonance imaging study of brain tissue from patients with migraine. J Neurol Neurosurg Psychiatry. 2003; 74: 501-503.
14. Valfre W, Rainero I, Bergui M, Pinessi L,. Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache. 2008; 48: 109-117.
15. Cutrer FM, Black DF,. Imaging findings of migraine. Headache. 2006; 46: 1095-1107.
16. Gouw AA, Seewann A, van der, Flier WM, et al. Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011; 82: 126-135.
17. Filippi M, Rocca MA, Barkhof F, et al.; Attendees of the Correlation between Pathological MRI Findings in MS Workshop. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 2012; 11: 349-360.
18. Hoque R, Ledbetter C, Gonzalez-Toledo E, et al. The role of quantitative neuroimaging indices in the differentiation of ischemia from demyelination: An analytical study with case presentation. Int Rev Neurobiol. 2007; 79: 491-519.
19. Zivadinov R, Bergsland N, Stosic M, et al. Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis. Neurol Res. 2008; 30: 816-826.
20. Vermeer SE, Hollander M, van, Dijk EJ, Hofman A, Koudstaal PJ, Breteler MMB,. Silent brain infarcts and white matter lesions increase stroke risk in general population. Stroke. 2003; 34: 1126-1129.
21. 1H spectra with LCModel. NMR Biomed. 2001; 14: 260-264.
22. Pagani E, Bizzi A, Di Salle F, De Stefano N, Filippi M,. Basic concepts of advanced MRI techniques. Neurol Sci. 2008; 29: S290-S295.
23. Lancaster JL, Andrews T, Hardies LJ, Dodd S, Fox PT,. Three-pool model of white matter. J Magn Reson Imaging. 2003; 17: 1-10.
24. Zhu YC, Dufouil C, Tzourio C, Chabriat H,. Silent brain infarcts: A review of MRI diagnostic criteria. Stroke. 2011; 42: 1140-1145.
25. Schwarcz A, Ursprung Z, Berente Z, et al. In vivo brain edema classification: New insight offered by large b-value diffusion-weighted MR imaging. J Magn Reson Imaging. 2007; 25: 26-31.
26. Moore GJ,. Proton magnetic resonance spectroscopy in pediatric neuroradiology. Pediatr Radiol. 1998; 28: 805-814.
27. Barkhof F, van Walderveen M,. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond B Biol Sci. 1999; 354: 1675-1686.
28. 1H MR spectroscopy of inflammation, infection and ischemia of the brain. Eur J Radiol. 2008; 67: 250-257.
29. Rumpel H, Lim WE, Chang HM, et al. Is myo-inositol a measure of glial swelling after stroke? A magnetic resonance study. J Magn Reson Imaging. 2003; 17: 11-19.
30. Wuerfel J, Bellmann-Strobl J, Brunecker P, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: A longitudinal perfusion MRI study. Brain. 2004; 127: 111-119.
31. Helms G,. Volume correction for edema in single-volume proton MR spectroscopy of contrast-enhancing multiple sclerosis lesions. Magn Reson Med. 2001; 46: 256-263.
32. Bakshi R, Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis: Current status and future prospects. Lancet Neurol. 2008; 7: 615-625.
33. 1H MRS imaging and diffusion-weighted MRI. J Neurol Sci. 2004; 220: 23-28.
34. Barber PA, Consolo HK, Yang Q, et al. Comparison of MRI perfusion imaging and single photon emission computed tomography in chronic stroke. Cerebrovasc Dis. 2001; 11: 128-136.
35. Saunders DE,. MR spectroscopy in stroke. Br Med Bull. 2000; 56: 334-345.
36. Oppenheimer SM, Bryan RN, Conturo TE, Soher BJ, Preziosi TJ, Barker PB,. Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. Magn Reson Med. 1995; 33: 61-68.
37. Sappey-Marinier D, Calabrese G, Hetherington HP, et al. Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn Reson Med. 1992; 26: 313-327.
38. Cutrer FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol. 1998; 43: 25-31.
39. Sanchez del Rio M, Bakker D, Wu O, et al. Perfusion weighted imaging during migraine: Spontaneous visual aura and headache. Cephalalgia. 1999; 19: 701-707.
40. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004; 113: 1447-1455.
41. Milhaud D, Bogousslavsky J, van, Melle G, Liot P,. Ischemic stroke and active migraine. Neurology. 2001; 57: 1805-1811.
42. Tietjen GE, Herial NA, White L, Utley C, Kosmyna JM, Khuder SA,. Migraine and biomarkers of endothelial activation in young women. Stroke. 2009; 40: 2977-2982.
43. Uzar E, Evliyaoglu O, Toprak G, et al. Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. J Headache Pain. 2011; 12: 239-243.
44. Singhal AB, Hajj-Ali RA, Topcuoglu MA, et al. Reversible cerebral vasoconstriction syndromes: Analysis of 139 cases. Arch Neurol. 2011; 68: 1005-1012.